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Abstract: 
Resistance to third-generation oxyimino cephalosporins is emerging, and it is considered a problem in medical 
field. Extended spectrum β-lactamase (ESBL) producing Acinetobacter baumannii have been noticed to be 
important cause of hospital infections. This study aimed to undertaken and determine the occurrence of ESBLs 
especially SHV, TEM and VEB β-lactamase types. A total of 770 clinical samples were collected from February 
to June, 2011. The A. baumannii isolates were identified according to API 20NE system. Phenotypic detection of 
ESBL was performed by using the combination disk, disk approximation  methods then confirmed by culturing 
on  ESBL CHROM agar medium.  The isolates were subjected to polymerase chain reaction (PCR) assays with 
specific primers for blaSHV, blaTEM and  blaVEB. Twelve (1.5%) A. baumannii isolates were recovered from 
clinical infections. All of them were β-lactam resistant (resistant to both ampicillin and amoxicillin). Of the β-
lactam resistant isolates, 8/12 (66.7%) were found to be disk combination test positive, and 10 (83.3%) isolates 
were confirmed as ESBL producers and gave heavy growth on ESBL CHROM agar. In PCR experiments using 
specific primers for blaSHV, blaTEM and  blaVEB genes, out of 12 A. baumannii isolates, three (25%) were harbored 
blaSHV  gene and only one (8.3%) isolate gave positive PCR results for blaTEM gene. This study demonstrate all 
isolates were blaVEB  negative. The present study concluded that the emerging of dissemination of ESBL 
producing A. baumannii in Najaf hospitals. 
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1 . Introduction 
 Acinetobacter baumannii has emerged over the last decade as a significant opportunistic pathogen. Although it 
is generally associated with benign colonization of hospitalized patients, it is responsible for about 10% of 
nosocomial infection in intensive care unit (ICU) patients, causing a wide range of infections (Levin et al, 2003; 
Poirel et al, 1999).  They are usually considered to be opportunistic pathogens, and of recent have been reported 
to cause a number of outbreaks of nosocomial infections in hospitalized patients like septicaemia, pneumonia, 
wound sepsis, endocarditis, meningitis and urinary tract infection (UTI) (Towner 1997). In Acinetobacter-
associated nosocomial infection, the major problem encountered by ICU clinicians relates to the readily 
transferable antimicrobial resistance expressed by this organism (Bergogne- Berezin 2001). In addition to 
intrinsic resistance, A. baumannii has the ability to acquire resistance to many major classes of antibiotics 
including newer _- lactams (Perilli et al, 1996). The presence of resistance plasmids (R-plasmids) is a significant 
feature of this organism, and plasmid profiling has been proposed as a method of epidemiological typing for 
Acinetobacter (Joshi 1998). Although A. baumannii colonizes hospitalized patients, approximately 30% of 
isolates are associated with frank infection in ICU patients and, in this setting, tend to demonstrate variable 
susceptibility profiles (Dy et al, 1999). 
Over the last 20 years many new β-lactam antibiotics, specifically designed to resist known β-lactamases, have 
been developed . However, almost invariably new β- lactamases have emerged to combat each new class of β-
lactams. Plasmid-mediate ESBLs emerged in Gram-negative bacilli in Europe in the 1980s (Zeba 2005 ). ESBL-
producing bacteria are typically resistant to penicillins, first-and second-generation cephaloporins as well as the 
third-generation oxyimino cephalosporins (Jacoby &Medeiros 1991).  
Typically, ESBLs are plasmid encoded but also present on chromosomes, often in association with integrons. 
These enzymes are derivatives, predominantly, of class A and D β-lactamases. Classical ESBLs evolved from 
class A, TEM (from TEM-1 or TEM-2) and SHV (from SHV-1) enzymes, and these remain the most prevalent 
types of ESBLs, though class D ESBLs (OXA family) have also been known for some time (Bradford 2001). 
Hence the fundamental aim of this study is to identify the occurrence of ESBL in A. baumannii isolates 
recovered from Hospital settings in Najaf. 
 
2. Materials and Methods   
2.1 Isolation and Identification 
A total of 770 clinical samples included (sputum (n= 450), , urine (n= 210), and burn wounds (n= 110)) were 
collected from patients in three separate hospitals (Al-Sader Medical City, Al-Hakeem General Hospital, Al-
Furat Teaching Hospital) in Najaf over five months period starting from February to June, 2011. Isolates were 
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recovered from clinical samples after culturing on MacConkey's agar (Himedia, India) and incubated for 
overnight at 37
o
C, non lactose fermenting bacteria (colorless or slightly beige) were subcultured and incubated 
for additional overnights. Suspected bacterial isolates which their cells are Gram negative coccobacillary or 
diplobacillus and negative to oxidase which further identified by the traditional biochemical test according to 
Holt et al. (1994) and MacFaddin (2000). Isolates were confirmed by API20 NE multi-test systems 
(BioMerieux ,France). 
2.2 Screening Test for β-lactam and Antibiotics Resistance 
 Ampicillin and amoxicillin were added separately, from stock solution, to the cooled Muller-Hinton agar at final 
concentration of 100 and 50  µg/ml, respectively. The medium poured into sterilized Petri dishes, then stored at 
4˚C. Isolates were cultured on Mueller–Hinton agar and their susceptibilities to different antibiotics were tested 
by disk diffusion method (NCCLs, 2003 ). Results were compared with E.coli ATCC 25922 as negative control. 
2.3 Phenotypic Detection of ESBL 
2.3.1 Disk Combination Test (Recommended by CLSI 2010)  
The phenotypic confirmation of potential ESBL-producing isolates was performed by using disk diffusion 
method. Cefotaxime alone and in combination with clavulanic acid were tested. Inhibition zone of  ≥ 5 mm 
increase in diameter for antibiotic tested in combination with clavulanic acid versus its zone when tested alone 
confirms an  ESBL producing isolate  (Cantarelli et al, 2007).    
2.3.2 Disk Approximation Test  
All β-lactamase producing isolates tested according to Batchoun et al. (2009). Antibiotic disks of cefotaxime 
(30µg), ceftazidime (30µg), ceftriaxione (30µg),  and azetreonam (30µg) were placed 15 mm (edge to edge) 
around a central disk of amoxi-clav (20µg amoxicillin plus 10 µg clavulanate) on Muller-Hinton agar plates 
seeded with organism being tested for ESBL production. Plates were incubated aerobically at 37
◦
C for 24 hr . 
Any augmentation (increase in diameter of inhibition zone) between the central amoxi-clav disk and any of the 
β-lactam antibiotic disks showing resistance or intermediate susceptibility was recorded, and the organism was 
thus considered as an ESBL producer. 
2.3.3 CHROM agar Technique phenotype detection of ESBLs producing isolates 
Extended spectrum β-lactamase CHROM agar plates were streaked in the same day of preparation by overnight 
growth of A. baumannii. The plates were incubated at 37
o
C for 24 hr according to manufacturer procedure. 
Growth of blue colonies indicated to  ESBL producer. The reference strain of E. coli ATCC 25922 was inhibited 
and used as negative control.  
2.4 Detection of ESBL bla Genes by Polymerase Chain Reaction  
2.4.1 DNA extraction 
Extraction of DNA from bacterial cells was performed by salting out method (Pospiech & Neumann, 1995) with 
some modification to prepare templet DNA. 
2.4.2 Polymerase Chain Reaction Protocols 
2.4.2.1 PCR Mixture and thermo cycling conditions 
The DNA template extracted from A. baumannii isolates were subjected to bla genes by PCR, the protocol was 
used depending on manufacturer's instruction and the right PCR cycling program parameters conditions were 
installed as in Table (1). 
2.4.2.2  Agarose Gel Electrophoresis 
All requirements, technical and preparations of agarose gel electrophoresis for DNA detection and analysis were 
performed by Bartlett & Stirling (1998). Finally, the gel was photographed using Biometra gel documentation 
system. 
 
3.  Results 
Among the 770 clinical samples were collected during study period  (Table 2), only 12 (1.5%) isolates had been 
identified as A. baumannii, all isolates (100%) were resistant to both ampicillin and amoxycillin. Fifty percent of 
A. baumannii isolates were recoverd from urine followed by 4(0.88%) from sputum and 2(1.8%) from burn 
wound.Production of ESBL was confirmed by three different methods, disk combination , disk approximation 
tests and ESBL CHROM agar (Table 3).  Only 8 (66.7%) isolates demonstrated enhancement of inhibition zone, 
suggesting production of ESBL by disk combination test, while no remarkable distinct change was noticed when 
using disk approximation test. In same time most isolate 10 (83.3%) were identified as ESBL producer by 
CHROM agar.In PCR experiments using specific primers for blaSHV and blaTEM and blaVEB , the results of table 
(4) show three (25%) isolates were harbored blaSHV  gene and only one (8.3%) isolate gave positive PCR results 
for blaTEM gene (Figure 1 and 2). This study demonstrates all isolates were blaVEB   negative.Consequently, table 
(5) show all isolates that harbored SHV and TEM types gene in their genotype appeared phenotypicaly as 
multidrug resistant isolates (resistant for more than three antibiotic classes). 
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4. Discussion 
A. baumannii is an important causes of nosocomial infections and has been associated with a wide variety of 
illness in hospitalized patients, especially patients in the intensive care units (Sinha et al, 2007). During a few 
decades A. baumannii tend to be multidrug resistance (MDR) due to their ability to develop antibiotic resistance 
(Kusradoze et al, 2011). Also, the extensive use of antimicrobial chemotherapy within hospital has contributed 
to the emergence and procreation of A. baumannii strains which are resistance to a wide range of antibiotic 
including broad spectrum β- lactams, aminoglycosides and flouroquinolones(Parisa et al, 2012). 
The main mechanisms of resistance to β- lactams in A. baumannii is enzymatic degradation by β- lactamase 
including the extended spectrum β- lactamase (blaTEM,  blaSHV, blaVEB and blaPER) and metalo-beta-lactamase 
(blaOXA51,23,24,and 58)  (Shahcheraghi et al, 2011). As shown in our results, 83% of isolates showed positive results 
for CHROM agar media compared with disc disc combination test (66.7%). This may due to the sensitivity of 
CHROM agar for the detection of enzyme compared with other methods. Also, our results showed no correlation 
between the existence of bla genes and phenotypic resistance against β- lactam antibiotics in A. baumannii. This 
results was in an agreement with other studies that confirmed a specific correlation between genotypic and 
phenotypic properties of β- lactam resistance among A. baumannii (Soroush et al, 2010; Srinivasan et al, 2009; 
Yan et al.,2009). Several studies reported that resistance to β- lactam antibiotic was largely due to existence of 
carbapenemase, ESBLs and metalo-beta-lactamase (Taherikalani et al, 2009; Lin et al.,2010; Srinivasan et 
al.,2009). The vast majority of ESBLs are acquired enzyme  encoded by plasmids, this confirmed our results 
which showed no correlation between genotype and phenotype properties(Parisa et al ,2012; Taherikalani et 
al ,2008 ; Papa et al ,2009). 
The acquired ESBLs are expressed at various levels and differ significantly in biochemical characteristics such 
as activity against specific β- lactams ( cefotaxim, ceftazidime and aztereonam) (Canton et al , 2012 : Kusradoz 
et al ,  2010 ).   
On the other hand, a high distribution of multiple antibiotic resistance was found in β- lactamase resistance A. 
baumannii (Table 5), this may due to the co-presence of other resistance mechanisms        ( other β- lactamase, 
effluex, altered permeability)( Parisa et al ,2012; Magiorakos et al , 2012; Uma et al ,2009)   
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Figure 1. Ethidium bromide-stained agarose gel of PCR amplified products from extracted DNA of A. baumannii 
isolates and amplified with blaSHV gene primers. The electrophoresis was performed at 70 volt for 1.5 hr.   Lane 
(L), DNA molecular size marker (l0000-bp ladder), Lane (A7, A10, A12) of  A. baumannii isolates show 
positive results with (753bp), Lanes (A1-A6 and 8, 9 ) show negative results. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 . Ethidium bromide-stained agarose gel of PCR amplified products from extracted DNA of  A. 
baumannii isolates and amplified with blaTEM gene primers. The electrophoresis was performed at 70 volt for 1.5 
hr.   Lane (L), DNA molecular size marker (l0000-bp ladder), Lane (A3) of  A. baumannii isolate show positive 
result with (822bp). 
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Table 1. Programs of PCR thermocycling conditions 
gene 
Temperature(
o
C ) / Time 
Cycle 
number Initial 
denaturation 
Cycling condition 
Final 
extension 
denaturation annealing extension 
blaSHV 94/30 sec 94/30 sec 60/1 min 72/1 min 72/10 min 35 
blaTEM 94/30 sec 94/30 sec 45/1 min 72/1 min 72/10 min 35 
blaVEB 93/3 min 93/1 min 55/1 min 72/1 min 72/7 40 
 
Table 2 . Number and percentage of β-lactam resistant A. baumannii isolates collected from clinical samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 . Phenotypic detection of ESBL production in A. baumannii isolates 
Type of 
sample 
No. of 
β-lactam resistant   
A. baumannii 
isolate 
No. (%) of phenotypic confirmed ESBL producer isolates 
Disk Combination 
Test 
Disk 
Approximation 
Test 
 
ESBL* CHROM 
agar 
technique 
Sputum 4 2 (50%) 0 (0%) 4 (100%) 
Urine 6 4 (66.7%) 0 (0%) 4(66.7%) 
Burn wound 2 2 (100%) 0 (0%) 2 (100%) 
Total 12 8 (66.7%) 0(0%) 10(83.3%) 
L.S.D. (0.05)  Samples = 9.143,   Methods = 8.94, *ESBL: Extended spectrum β-lactamase 
Clinical sample No. 
No. (%) of  β-lactam resistant   
A. baumannii isolate 
Sputum 450 4 (0.88%) 
Urine 210 6 (2.8%) 
Burn swab 110 2 (1.8%) 
Total 770 12 (1.5%) 
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Table 4 .  Molecular detection of bla genes in ESBL producing A. baumannii isolates 
Type of sample 
No. of 
β-lactam resistant  A. 
baumannii isolate 
Molecular detection of ESBL bla genes 
blaSHV blaSHV blaSHV 
Sputum 4 1 (25%) 0 0 
Sputum 6 0 0 0 
Burn wound 2 2 (100%) 1 (33.3%) 0 
Total 12 3 (25%) 1 (8.3%) 0 
 
Table 5 . Antibiotic susceptibility profiles of multi-drug resistant A. baumannii isolates. 
 
PY, Carbenicillin; PRL, Piperacillin; TIC, Ticarcillin; AC, Amoxi-clav; CFX, Cefexime; FOX, Cefoxitin; CAZ, 
Ceftazidime; CTX, Cefotaxime; CI, Ceftriaxone; FEP, Cefepime; IMP, Imipenem; MEM, Meropenem; ATM, 
Aztreonam; AK, Amikacin; CN, Gantamycin; TOB, Tobramycin;;CIP, Ciprofloxacin; LEV, Levofloxacin; GT, 
Gatifloxacin; TE, Tetracyclin; TEP, Trimethoprime  
 
Isolate Genotype Antibiotic resistant 
AS3 SHV 
Ac, CTX, CI,  CAZ, ATM, FOX,  MEM, FEP, TOB, AK, CN,  CIP, 
GT, LEV , TE, PRL,  TIC, PY 
AB4 SHV 
Ac, CTX, CI,  CAZ, ATM, FOX, MEM, FEP, TOB, AK, CN, CIP, 
GT,  LEV , PRL,  TIC, PY 
AB6 TEM 
CTX, CAZ, ATM, FOX, FEP, TOB, AK, CN,  TEP, TE, PRL,  TIC, 
PY 
AB9 SHV 
AC, CTX, CI,  CAZ, ATM, FOX, IPM, MEM, FEP, TOB, AK, CN,  
TEP, CIP, GT, TE, PRL,  TIC, PY 
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